Benitec Biopharma (BNTC) Non-cash Items (2025)

Benitec Biopharma's (BNTC) quarterly Non-cash Items came in at $14.8 million in Q4 2025, up 91.8% quarter-over-quarter from $7.7 million in Q2 2025.

Benitec Biopharma (BNTC) Non-cash Items (2025) Analysis & Trends

Benitec Biopharma has disclosed Non-cash Items across 1 years of filings, most recently posting $14.8 million for Q4 2025.

Non-cash Items for Q4 2025 came in at $14.8 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $14.8 million (changed N/A YoY), and the FY2025 annual result was $7.7 million, changed N/A from the prior year.
Non-cash Items came in at $14.8 million for Q4 2025 at Benitec Biopharma, up from $7.7 million in the prior quarter.
In the past five years, Non-cash Items ranged from a high of $14.8 million in Q4 2025 to a low of $7.7 million in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	788,338.31 Bn	788,338.28 Bn	-
2	Belite Bio	56,560.00 Bn	56,560.00 Bn	-
3	Quantum Biopharma	17,329.30 Bn	17,329.30 Bn	-
4	Legend Biotech	3,341.00 Bn	3,340.71 Bn	242.10 Mn
5	Akari Therapeutics	1,727.91 Bn	1,727.91 Bn	-
6	Evaxion A	1,536.68 Bn	1,536.67 Bn	-
7	Psyence Biomedical	238.34 Bn	238.33 Bn	-
8	Vertex Pharmaceuticals	113.42 Bn	106.17 Bn	2.59 Bn
9	Abivax	95.45 Bn	95.45 Bn	-
10	Benitec Biopharma	488.21 Mn	488.21 Mn	-

Download Data